Now that health reform is law, a local not-for-profit group, Better Healthcare for Indiana, wants to help Indiana community
leaders use the law to slow runaway medical spending while improving the health of their citizens.
WellPoint Inc.'s announcement of comparative effectiveness research guidelines last week marks a new era for U.S. drugmakers.
The Indianapolis-based health insurer will use studies that compare the effectiveness of one drug against another as a complement
to typical clinical trial research that compares a drug against a placebo sugar pill.
Don Stumpp, manager of payer contracting at Indianapolis-based physician group American Health Network and president of the Indiana Medical Group Management Association, discussed the impact of the health care reform law on primary care physicians as well as the near-constant threat of a sharp cut in Medicare reimbursement.
Indianapolis-based Eli Lilly and Co. spent about $2.3 million in the first quarter of 2010 lobbying the federal government
on health care reform, Medicare reimbursement and trade issues among other topics.
Moody's Investors Service on Friday lowered its rating outlook on drugmaker Eli Lilly and Co. to "negative"
from "table" due in part to the looming expiration of patents protecting key drugs from generic competition.
The estimate released Friday from an outside actuary hired by the state is lower than the actuary’s “worst case scenario”
given two weeks ago.
The unnamed venture fund will be based in Brisbane, and will focus on biotechnology investments in Australia and southeastern
Asia.
Companies in the health care supply chain need to engage in more strategic, long-term preparation even as the industry faces
uncertainties and upheaval, MIT expert tells local conference attendees.
Arcadia Resources Inc. is planning a $3.9 million expansion of its Indianapolis headquarters and pharmacy operations, the
company said Thursday morning, confirming that it plans to add as many as 930 jobs by 2013.
The price increase was fueled by the debate over the health-care overhaul in Washington, D.C., Medco Health Solutions Inc. CEO David Snow said.
Executives of the health care services provider will be joined by Gov. Mitch Daniels and Mayor Greg Ballard for a Thursday
morning announcement at the company's headquarters.
Ball Memorial Hospital in Muncie and Bloomington Hospital were among nine U.S. hospitals that had been charged with submitting
false claims to the Medicare program.
Dr. Rob Stone wants the giant health insurer to convert to not-for-profit status and put him, an advocate of national health
insurance, on the company’s board.
If Clarian Health CEO Dan Evans were investing in health care real estate, he’d make bets in three new things: smaller,
denser clinics with lots of computer equipment to do telemedicine; medical office buildings populated by physician assistants;
and nursing homes with a strong relationship with a hospital.
Bioanalytical Systems Inc. narrowed its losses in the second fiscal quarter despite a 2 percent drop in revenue, the West
Lafayette-based contract research firm said late last week.
Indiana has named its first coordinator for overseeing a $10.3 million effort to shift the state's hospitals and clinics
from paper medical records to electronic files.
U.S. Health and Human Services Secretary Kathleen Sebelius said having insurers as "good partners" is part of health
care reform, but she made no promises Friday to tone down criticism of an industry the Obama administration has attacked repeatedly.
Gift will be used for a pediatric research facility to better identify how genetic and environmental factors contribute to
diseases in children.
West Lafayette-based Bioanalytical Systems Inc. has promoted Anthony S. Chilton to CEO following the retirement of top executive
Richard M. Shepperd earlier this year.
U.S. companies, including Eli Lilly, amassed at least $1 trillion in foreign profits not taxed in the U.S. as of the end of
last year. That cumulative total increased 70 percent over three years.
